Evgeniya A. Sergeeva

Learn More
Small diameter arterial bypass grafts are considered as unmet clinical need since the current grafts have poor patency of 25% within 5 years. We have developed a 3D scaffold manufactured from natural and synthetic biodegradable polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and poly(𝜀-caprolactone) (PCL), respectively. Further to improve the(More)
The combination of a natural polymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and a synthetic hydrophobic polymer poly(ε-caprolactone) (PCL) is promising for the preparation of biodegradable and biocompatible small-diameter vascular grafts for bypass surgery. However, physico-mechanical properties and endothelialization rate of PHBV/PCL grafts(More)
The reactions of agostic (CH3···Rh) complexes [3-{(1-3-η(3))-1,1,2-trimethylallyl}-1-R-2-R'-closo-3,1,2-RhC2B9H9] [1: R = R' = Me; 2: R,R' = μ-(ortho-xylylene); 3: R = Ph, R' = Me] in a cooled (+5 °C) toluene solution with the strong non-nucleophilic base N,N,N',N'-tetramethylnaphthalene-1,8-diamine (tmnd) formally involve a linear coupling of the π-allyl(More)
  • 1